Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 20, 2013 - Issue 4
351
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Description of transthyretin S50A, S52P and G47A mutations in familial amyloidosis polyneuropathy

, &
Pages 221-225 | Received 07 Jan 2013, Accepted 15 Jul 2013, Published online: 20 Sep 2013

References

  • Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408–27
  • Planté-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol 2011;10:1086–97
  • Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amylodotic polyneuropathy (FAP) type I in Povoa do Varzim and Vila do Conde (North of Portugal). Am J Med Genet 1995;60:512–21
  • Cappellari, M, Cavallaro T, Ferrarini M, Cabrini I, Taioli F, Ferrari S, Merlini G, et al. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. J Peripher Nerv Syst 2011;16:119–29
  • Zeldenrust S. Genotype-phenotype correlation in FAP. Amyloid 2012;19:22–4
  • Planté-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2007;69:693–8
  • Magy N, Valleix S, Grateau G, Algros M, Romain G, Kantelip B, Delpech M, et al. Transthyretin mutation TTRGly47 associated with familial amyloid polyneuropathy in a French family. Amyloid 2002;9:272–5
  • Planté-Bordeneuve V, Carayol J, Ferreira A, Adams D, Clerget-Darpoux F, Misrahi M, Said G, et al. Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families. J Med Genet 2003;40:e120
  • Ferlini A, Patrosso MC, Repetto M, Frattini A, Villa A, Fini S, Salvi F, et al. A new mutation (TTR Ala-47) in the transthyretin gene associated with hereditary amyloidosis. Hum Mutat 1994;4:61–4
  • Dyck PJ, Zimmerman I, Gillen DA, Johnson D, Karnes JL, O'Brien PC. Cool, warm and heat-pain detection thresholds: testing methods and inference about anatomical distribution of receptors. Neurology 1993;43:1500–8
  • Geber C, Klein T, Azad S, Birklein F, Gierthmühlen J, Huge V, Lauchart M, et al. Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multicentre study. Pain 2011;152:148–56
  • Jablecki CK, Andary MT, Di Benedetto M, Horowitz SH, Marino RJ, Rosenbaum RB, Shields RW Jr, et al. American Association of Electrodiagnostic Medicine Guidelines for outcome studies in electrodiagnostic medicine. Muscle Nerve 1996;19:1626–35
  • Takahashi N, Ueno S, Uemichi T, Fujimura H, Yorifuji S, Tarui S. Amyloid polyneuropathy with transthyretin Arg50 in a Japanese case from Osaka. J Neurol Sci 1992;112:58–64
  • Munar-Qués M, MasJuan J, Coelho T, Moreira P, Viader-Farré C, Saravia M. Familial amyloid polyneuropathy associated with TTRSer50Arg mutation in two Iberian families presenting a novel single base change in the mutant gene. Amyloid 2007;14:147–52
  • González-Duarte A, Cardenas Soto K, Martínez-Baños D, Arteaga-Vazquez J, Barrera F, Berenguer-Sanchez M, Cantú-Brito C, et al. Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation. Amyloid 2012;19:171–6
  • Ikeda S. Transthyretin Val30Met familial amyloid polyneuropathy: a considerably different clinical picture and natural course in endemic and non-endemic areas. J Neurol Neurosurg Psychiatry 2012;83:121
  • Planté-Bordeneuve V, Lalu T, Misrahi M, Reilly M.M, Adams D, Lacroiix C, Said G. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology 1998;51:708–14
  • Ikeda S. Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy: clinical and genetic heterogeneity. Neurology 2002;58:1001–7
  • Hellman U, Alarcon F, Lundgren HE, Suhr OB, Bonaiti-Pellié C, Planté-Bordeneuve V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid 2008;15:181–6
  • Rapezzi C, Riva L, Quarta C, Perugini E, Salvi F, Longhi S, Ciliberti P, et al. Gender-related risk of myocardial involvement in systemic amyloidosis. Amyloid 2008;15:40–8
  • Yamamoto K, Ikeda S, Hanuy H. A pedigree analysis with minimized ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet 1998;35:23–30
  • Soares M, Buxbam J, Sirugo G, Coelho T, Sousa A, Kastner D, Saraiva MJ, et al. Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions. Hum Genet 1999;104:480–5
  • Koike H, Misu K-i, Ikeda S-i, Ando Y, Nakazato M, Ando E, Yamamoto M, et al. Study Group for Hereditary Neuropathy in J. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol 2002;59:1771–6
  • Holmgren G, Costa PM, Anderson C, Asplund K, Steen L, Beckman L, Nylander PO, et al. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 1994;31:351–4
  • Koide H, Tanaka F, Hashimoto R, Tomita M, Kawagashira Y, Lijima M, Fujitake J, et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry 2012;83:152–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.